Skip to main content

National Differences in the Management of Bladder Cancer

  • Chapter
Carcinoma of the Bladder

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 163 Accesses

Abstract

The treatment of bladder cancer is very similar in Western Europe and the United States. Nevertheless, certain differences in treatment approach can be identified between countries. Within Europe, the preferred specific treatment protocols in France, Spain, and other south European countries are somewhat different from those in the north European countries such as the United Kingdom, Germany, the Benelux countries, and the Scandinavian countries. Comparing European countries and the United States, on the other hand, there are certain differences in attitude toward the use of surgical techniques and radiation therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Beer M, Jocham D, Beer A, Staehler G (1989) Adjuvant laser treatment of bladder cancer: 8 years’ experience with the ND-YAG laser 1064 NM. Br J Urol 63: 476–478

    Article  PubMed  CAS  Google Scholar 

  • Bouffioux C, Kurth KH, Bono A, Oosterlinck W, Kruger CB, De Pauw M, Sylvester R (1995) Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. European Organization for Research and Treatment of Cancer Genitourinary Group. J Urol 153: 934–941

    Article  PubMed  CAS  Google Scholar 

  • Bricker EM (1950) Bladder substitution after pelvic evisceration. Surg Clin North Am 30: 1511

    PubMed  CAS  Google Scholar 

  • Catalona WJ (1992) Urothelial tumors of the urinary tract. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED (eds) Campbell’s urology, 6th edn. Saunders, Philadelphia, pp 1094–1158

    Google Scholar 

  • Crawford ED, Das S, Smith JA (1987) Preoperative radiation therapy in the treatment of bladder cancer. Urol Clin North Am 14: 781

    PubMed  CAS  Google Scholar 

  • D’Hallewin MA, Baert L (1995) Long term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder. Urology 45: 763–767

    Article  PubMed  Google Scholar 

  • Duncan W, Quilty PM (1986) The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage x-ray therapy. Radiother Oncol 7: 299–310

    Article  PubMed  CAS  Google Scholar 

  • Dunst J, Sauer R, Schrott KM, Kühn R, Wittekind C, Altendorf-Hofmann AA (1994) Organ-sparing treatment of advanced bladder carcinoma: a 10-year experience. Int J Radiat Oncol Biol Phys 30: 261–266

    Article  PubMed  CAS  Google Scholar 

  • Fisch M, Wammack R, Steinbach F, Muller SC, Hohenfellner R (1993) Sigma-rectum pouch ( Mainz pouch II ). Urol Clin North Am 20: 561–569

    Google Scholar 

  • Gospodarowicz MK, Quilty PM, Scalliet P, et al. (1995) The place of radiation therapy as definitive treatment of bladder cancer. Int J Urol 2 (Suppl 2): 41–48

    Article  PubMed  Google Scholar 

  • Hautmann RE (1991) The ileal neobladder. Acta Urol Belg 59: 227–240

    PubMed  CAS  Google Scholar 

  • Huland H, Klöppel G, Otto U, et al. (1990) Comparison of different schedules of cytostatic intravesical installations in patients with superficial bladder carcinoma. First evaluation of a prospective multicenter study with 419 patients. J Urol 144: 68

    PubMed  CAS  Google Scholar 

  • Huland H, Otto U, Droese M, Klöppel G (1984) Long-term mitomycin installation after transurethral resection of superficial bladder carcinoma: influence of recurrence, progression and survival. J Urol 132: 27–33

    PubMed  CAS  Google Scholar 

  • Jahnson S, Pedersen J, Westman G (1991) Bladder carcinoma - a 20-year review of radical irradiation therapy. Radiother Oncol 22: 111–117

    Article  PubMed  CAS  Google Scholar 

  • Jakse G, Frommhold H (1988) Radiotherapy and chemothe- rapy in locally advanced bladder cancer. Eur Urol 14: 45

    PubMed  Google Scholar 

  • Kaufaman DS, Shipley WU, Heney NM, et al. (1991) The integration of transurethral surgery, chemotherapy and radiation with bladder sparing in patients with invasive bladder cancer: an update of prognostic factors in a prospective trial (meeting abstract). Proc Annu Meet Am Soc Clin Oncol 10: A516

    Google Scholar 

  • Kock NG, Ghoneim MA, Lycke KG (1988) Urinary diversion to the augmented and valved rectum: preliminary results with a novel surgical procedure. J Urol 140: 1375

    PubMed  CAS  Google Scholar 

  • Koiso K, Shipley W, Keuppens F, et al (1995) The status of bladder-preserving therapeutic strategies in the manag-ment of patients with muscle-invasive bladder cancer. Int J Urol 2 (Suppl 2): 49–57

    Article  PubMed  Google Scholar 

  • Kriegmair M, Waidelich R, Baumgartner R, Lumper W, Ehsan A, Hofstetter A (1994) (Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?) Die photodynamische Therapie ( PDT) des oberflachlichen Harnblasenkarzinoms. Eine Alternative zur radikalen Zystektomie? Urologe [A] 33: 276–280

    CAS  Google Scholar 

  • Lample A, Hohenfellner M, Schultz-Lampel D, Thuroff JW (1995) In situ tunneled bowel flap tubes: 2 new techniques of a continent outlet for Mainz pouch cutaneous diversion. J Urol 153: 308–315

    Article  Google Scholar 

  • Lukkarinen O, Paul C, Hellstrom, P, et al (1991) Intravesical epirubicin with and without verapamil for the prophylaxis of superficial bladder tumors. Scand J Urol Nephrol 25: 25–28

    Article  PubMed  CAS  Google Scholar 

  • Martinez-Pineiro JA, Gonzalez-Martin M, Arocena F, et al. (1995) Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: a prospective randomized phase III study. J Urol 153: 964–973

    Article  PubMed  CAS  Google Scholar 

  • Medical Research Council Working Party on Urological Research (1994) The effect of intravesical thiotepa on tumor recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer. A further report with long-term follow-up of a Medical Research Councial randomized trial. Medical Research Council Working Party on Urological Cancer, Subgroup on Superficial Baladder Cancer. Br J Urol 73: 632–638

    Article  Google Scholar 

  • Moore MJ, O’Sullivan B, Tannock IF (1988) How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol 1736: 1736–1745

    Google Scholar 

  • Mori K, Lamm KL, Crawford DE (1988) A trial of bacillus Calmette-Guérin vs. adriamycin in superficial bladder cancer: a Southwest Oncology Group Study. Urol Int 41: 254

    Article  Google Scholar 

  • Mulders PF, Hoekstra WJ, Heybroek RP, Schapers ER, Verbeek AL, Oosterhof GO, Debruyne FM (1994) Prognosis and treatment of T1G3 bladder tumors. A prognostic factor analysis of 121 patients. Dutch South Eastern Bladder Cancer Study Group (see comments). Eur J Cancer 30A: 914–917

    Article  PubMed  CAS  Google Scholar 

  • Newling D (1990) Intravesical therapy in the management of superficial transitional cell carcinoma of the bladder: the experience of the EORTC GU Group. Br J Cancer 61: 497–499

    Article  PubMed  CAS  Google Scholar 

  • Newling DW, Robinson MR, Smith PH, et al. (1995) Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomized phase III study performed by the EORTC GU Group. EORTC Genito-Urinary Tract Cancer Cooperative Group. Eur Urol 27: 110–116

    PubMed  CAS  Google Scholar 

  • Oosterlinck W, Kurth KH, Schrodr F, Sylvester R, Hammond B (1993) A plea for cold biopsy, fulguration and immediate bladder instillation with epirubicin in small superficial bladder tumors. Data from the EORTC GU Group Stury 30863. Eur Urol 23: 457–459

    PubMed  CAS  Google Scholar 

  • Pavone-Macaluso M, Tripi M, Ingargiola GB, Corselli G, Pavone C, Serretta V (1993) Current views on intravesical treatment and chemoprophylaxis of superficial bladder cancer. The present role of epirubicin and doxorubicin. J Chemother 5: 207–211

    PubMed  CAS  Google Scholar 

  • Prout GR Jr, Shipley WU, Kaufman DS, Giffin PP, Heney NM (1991) Interval report of a phase I-II study utilizing multiple modalities in the treatment of invasive bladder cancer. A bladder-sparing trial. Urol Clin North Am 18: 547–554

    PubMed  Google Scholar 

  • Rowland RG, Mitchell ME, Bihrle P (1987) Indiana continent urinary reservoir. J Urol 137: 1136

    PubMed  CAS  Google Scholar 

  • Schwaibold H, Klingenberger HJ, Huland H (1994a) Langzeitergebnisse einer intravesikalen Rezidivprophylaxe mit Mitomycin C and Adriamycin bei Patienten mit oberflächlichem Harnblasenkarzinom. Urologe [A] 33: 479–483

    CAS  Google Scholar 

  • Shipley WU, Prout GR Jr, Einstein AB, et al (1987) Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA 258: 931–935

    Article  PubMed  CAS  Google Scholar 

  • Stoeckle M, Meyenburg W, Wellek S, et al. (1995) Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience. J Urol 153: 47–52

    Article  Google Scholar 

  • van der Meijden AP, Kurth KH, Oosterlinck W, Debruyne FM (1992) Intravesical therapy with adriamycin and 4epirubicin for superficial bladder cancer: the experience of the EORTC GU Group. Cancer Chemother Pharmacol 30 (Suppl): S95–S98

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Heilmann, HP. (1998). National Differences in the Management of Bladder Cancer. In: Petrovich, Z., Baert, L., Brady, L.W. (eds) Carcinoma of the Bladder. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60258-0_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60258-0_29

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64323-1

  • Online ISBN: 978-3-642-60258-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics